Agents of Change: re(AI)magining the Future of Healthcare

OVERVIEW

The next wave of AI isn't waiting for instructions—it's acting on them.

Across healthcare, agentic AI systems are beginning to move beyond generating insights to coordinating actions: accelerating drug discovery, streamlining regulatory submissions, orchestrating clinical and operational workflows, and reducing the friction that consumes scarce human expertise. What began as copilots that assist people may soon evolve into digital colleagues that participate directly in how work gets done.

For technology, data, engineering and strategy leaders, this shift demands more than another technology investment. It requires a fundamental rethink of organisational design, governance, accountability and workforce strategy. As AI agents become capable of executing tasks, coordinating decisions and operating across functions, healthcare organisations must determine where autonomy creates value, where human oversight remains essential, and how trust can be built at scale.

The opportunity is significant. Organisations that successfully operationalise agentic AI could unlock new levels of productivity, speed and innovation across the healthcare value chain. Yet in an industry where the consequences of error are measured not only in cost but in patient outcomes, compliance risk and reputation, the stakes are uniquely high.

This private discussion will explore what it takes to move from experimentation to enterprise adoption—and whether healthcare organisations are truly prepared for a future in which AI becomes an active participant in the workforce.

Discussion Questions

• Where in your organisation is the technical, operational and cultural foundation already in place to support AI agents—and where are the most significant barriers to adoption?
• As AI moves from augmenting human work to taking action within defined workflows, how should healthcare organisations rethink governance, accountability and trust?
• Which use cases across clinical operations, R&D, regulatory, commercial and corporate functions are most likely to deliver measurable value first, and what will separate the leaders from the followers?